Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Common stock purchase or sale:
Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
2021-07-06 Sale |
2021-07-08 7:40 pm |
Arcutis Biotherapeutics Inc. | ARQT | Watanabe Todd Franklin President and CEO |
1,750 | $26.58 | $46,515 | 942,428 (Indirect Direct) |
View |
2021-07-01 Sale |
2021-07-06 7:14 pm |
Arcutis Biotherapeutics Inc. | ARQT | Welgus Howard G. Director |
2,200 | $26.13 | $57,476 | 251,110 (Indirect Direct) |
View |
2021-06-24 Sale |
2021-06-28 4:11 pm |
Arcutis Biotherapeutics Inc. | ARQT | CHAUDHURI BHASKAR Director |
7,484 | $27.5 | $205,810 | 891,372 (Indirect Direct) |
View |
2021-06-21 Sale |
2021-06-23 5:47 pm |
Arcutis Biotherapeutics Inc. | ARQT | CHAUDHURI BHASKAR Director |
2,516 | $27.5 | $69,190 | 898,856 (Indirect Direct) |
View |
2021-06-07 Sale |
2021-06-09 4:35 pm |
Arcutis Biotherapeutics Inc. | ARQT | Watanabe Todd Franklin President and CEO |
1,750 | $26.35 | $46,113 | 936,801 (Indirect Direct) |
View |
2021-06-01 Sale |
2021-06-03 4:39 pm |
Arcutis Biotherapeutics Inc. | ARQT | CHAUDHURI BHASKAR Director |
10,000 | $27.5 | $275,000 | 901,372 (Indirect Direct) |
View |
2021-06-01 Sale |
2021-06-03 4:37 pm |
Arcutis Biotherapeutics Inc. | ARQT | Welgus Howard G. Director |
2,200 | $27.09 | $59,603 | 283,967 (Indirect Direct) |
View |
2021-04-20 Sale(A) |
2021-05-19 6:43 pm |
Arcutis Biotherapeutics Inc. | ARQT | CHAUDHURI BHASKAR Director |
10,000 | $28.06 | $280,568 | 911,372 (Indirect Direct) |
View |
2021-05-07 Sale |
2021-05-11 11:47 am |
Arcutis Biotherapeutics Inc. | ARQT | Watanabe Todd Franklin President and CEO |
750 | $35 | $26,250 | 937,545 (Indirect Direct) |
View |
2021-05-05 Sale |
2021-05-07 11:29 am |
Arcutis Biotherapeutics Inc. | ARQT | Watanabe Todd Franklin President and CEO |
1,750 | $34 | $59,500 | 938,295 (Indirect Direct) |
View |
2021-05-03 Sale |
2021-05-05 2:05 pm |
Arcutis Biotherapeutics Inc. | ARQT | Welgus Howard G. Director |
2,200 | $34.79 | $76,547 | 284,555 (Indirect Direct) |
View |
2021-04-30 Sale |
2021-05-04 3:00 pm |
Arcutis Biotherapeutics Inc. | ARQT | Watanabe Todd Franklin President and CEO |
1,500 | $35 | $52,500 | 804,553 (Indirect Direct) |
View |
2021-04-20 Sale |
2021-04-22 8:17 pm |
Arcutis Biotherapeutics Inc. | ARQT | CHAUDHURI BHASKAR Director |
10,000 | $28.06 | $280,568 | 911,372 (Indirect Direct) |
View |
2021-04-05 Sale |
2021-04-06 5:30 pm |
Arcutis Biotherapeutics Inc. | ARQT | Watanabe Todd Franklin President and CEO |
1,750 | $29.93 | $52,378 | 806,053 (Indirect Direct) |
View |
2021-04-01 Sale |
2021-04-05 5:33 pm |
Arcutis Biotherapeutics Inc. | ARQT | Welgus Howard G. Director |
2,200 | $29.49 | $64,880 | 284,100 (Indirect Direct) |
View |
2021-03-22 Sale |
2021-03-24 11:33 am |
Arcutis Biotherapeutics Inc. | ARQT | CHAUDHURI BHASKAR Director |
10,000 | $31.1 | $311,021 | 921,372 (Indirect Direct) |
View |
2021-03-10 Sale |
2021-03-11 3:59 pm |
Arcutis Biotherapeutics Inc. | ARQT | Smither John W Chief Financial Officer |
1,750 | $32.9 | $57,575 | 178,018 (Indirect Direct) |
View |
2021-03-05 Sale |
2021-03-05 3:56 pm |
Arcutis Biotherapeutics Inc. | ARQT | Watanabe Todd Franklin President and CEO |
1,750 | $30.55 | $53,463 | 907,003 (Indirect Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
2021-07-06 Exercise |
2021-07-08 7:40 pm |
N/A 2029-03-13 |
Arcutis Biotherapeutics Inc. | ARQT | Watanabe Todd Franklin President and CEO |
1,750 | $0 | 942,428 (Direct) |
View |
2021-07-06 Exercise |
2021-07-08 7:40 pm |
N/A N/A |
Arcutis Biotherapeutics Inc. | ARQT | Watanabe Todd Franklin President and CEO |
1,750 | $1.6806 | 942,428 (Direct) |
View |
2021-07-01 Exercise |
2021-07-06 7:14 pm |
N/A 2029-03-13 |
Arcutis Biotherapeutics Inc. | ARQT | Welgus Howard G. Director |
2,200 | $0 | 251,110 (Direct) |
View |
2021-07-01 Exercise |
2021-07-06 7:14 pm |
N/A N/A |
Arcutis Biotherapeutics Inc. | ARQT | Welgus Howard G. Director |
1,028 | $6.522 | 251,110 (Direct) |
View |
2021-07-01 Exercise |
2021-07-06 7:14 pm |
N/A N/A |
Arcutis Biotherapeutics Inc. | ARQT | Welgus Howard G. Director |
1,172 | $1.6806 | 251,110 (Direct) |
View |
2021-06-18 Other |
2021-06-22 6:35 pm |
N/A N/A |
Arcutis Biotherapeutics Inc. | ARQT | Watanabe Todd Franklin President and CEO |
7,377 | $0 | 820,170 (Indirect) |
View |
2021-06-09 Option Award |
2021-06-16 2:07 pm |
N/A 2031-06-09 |
Arcutis Biotherapeutics Inc. | ARQT | LIN SUE-JEAN Director |
25,723 | $0 | 25,723 (Direct) |
View |
Ownership |
2021-06-16 2:06 pm |
N/A N/A |
Arcutis Biotherapeutics Inc. | ARQT | LIN SUE-JEAN Director |
0 | $0 | 300 (Direct) |
View |
2021-06-09 Option Award |
2021-06-11 5:30 pm |
N/A 2031-06-09 |
Arcutis Biotherapeutics Inc. | ARQT | Sun Ricky Director |
13,391 | $0 | 13,391 (Direct) |
View |
2021-06-09 Option Award |
2021-06-11 4:38 pm |
N/A 2031-06-09 |
Arcutis Biotherapeutics Inc. | ARQT | Welgus Howard G. Director |
13,391 | $0 | 13,391 (Direct) |
View |
2021-06-09 Option Award |
2021-06-11 4:37 pm |
N/A 2031-06-09 |
Arcutis Biotherapeutics Inc. | ARQT | TURNER JOSEPH L Director |
13,391 | $0 | 13,391 (Direct) |
View |
2021-06-09 Option Award |
2021-06-11 4:36 pm |
N/A 2031-06-09 |
Arcutis Biotherapeutics Inc. | ARQT | Gilbert Halley E Director |
13,391 | $0 | 13,391 (Direct) |
View |
2021-06-09 Option Award |
2021-06-11 4:36 pm |
N/A 2031-06-09 |
Arcutis Biotherapeutics Inc. | ARQT | Curran Terrie Director |
13,391 | $0 | 13,391 (Direct) |
View |
2021-06-09 Option Award |
2021-06-11 4:35 pm |
N/A 2031-06-09 |
Arcutis Biotherapeutics Inc. | ARQT | Heron Patrick J Director 10% Owner |
13,391 | $0 | 13,391 (Direct) |
View |
2021-06-09 Option Award |
2021-06-11 4:34 pm |
N/A 2031-06-09 |
Arcutis Biotherapeutics Inc. | ARQT | CHAUDHURI BHASKAR Director |
13,391 | $0 | 13,391 (Direct) |
View |
2021-06-07 Exercise |
2021-06-09 4:35 pm |
N/A 2029-03-13 |
Arcutis Biotherapeutics Inc. | ARQT | Watanabe Todd Franklin President and CEO |
1,750 | $0 | 936,801 (Direct) |
View |
2021-06-07 Exercise |
2021-06-09 4:35 pm |
N/A N/A |
Arcutis Biotherapeutics Inc. | ARQT | Watanabe Todd Franklin President and CEO |
1,750 | $1.6806 | 936,801 (Direct) |
View |
2021-06-01 Exercise |
2021-06-03 4:37 pm |
N/A 2029-03-13 |
Arcutis Biotherapeutics Inc. | ARQT | Welgus Howard G. Director |
2,200 | $0 | 283,967 (Direct) |
View |
2021-06-01 Exercise |
2021-06-03 4:37 pm |
N/A N/A |
Arcutis Biotherapeutics Inc. | ARQT | Welgus Howard G. Director |
1,029 | $6.522 | 283,967 (Direct) |
View |
2021-06-01 Exercise |
2021-06-03 4:37 pm |
N/A N/A |
Arcutis Biotherapeutics Inc. | ARQT | Welgus Howard G. Director |
1,171 | $1.6806 | 283,967 (Direct) |
View |
2021-05-21 Exercise |
2021-05-25 3:10 pm |
N/A 2029-03-13 |
Arcutis Biotherapeutics Inc. | ARQT | Welgus Howard G. Director |
1,612 | $0 | 267,249 (Direct) |
View |
2021-05-21 Exercise |
2021-05-25 3:10 pm |
N/A N/A |
Arcutis Biotherapeutics Inc. | ARQT | Welgus Howard G. Director |
1,222 | $0.5802 | 267,249 (Direct) |
View |
2021-05-21 Exercise |
2021-05-25 3:10 pm |
N/A N/A |
Arcutis Biotherapeutics Inc. | ARQT | Welgus Howard G. Director |
390 | $1.6806 | 267,249 (Direct) |
View |
2021-05-10 Other |
2021-05-12 5:37 pm |
N/A N/A |
Arcutis Biotherapeutics Inc. | ARQT | Frazier Life Sciences VIII L.P. FHM LIFE SCIENCES VIII L.L.C. Heron Patrick J Topper James N FHM LIFE SCIENCES VIII L.P. 10% Owner |
2,205,132 | $0 | 10,790,280 (Direct) |
View |
2021-05-07 Exercise |
2021-05-11 11:47 am |
N/A 2029-03-13 |
Arcutis Biotherapeutics Inc. | ARQT | Watanabe Todd Franklin President and CEO |
750 | $0 | 937,545 (Direct) |
View |
2021-05-07 Exercise |
2021-05-11 11:47 am |
N/A N/A |
Arcutis Biotherapeutics Inc. | ARQT | Watanabe Todd Franklin President and CEO |
750 | $1.6806 | 937,545 (Direct) |
View |
2021-05-05 Exercise |
2021-05-07 11:29 am |
N/A 2029-03-13 |
Arcutis Biotherapeutics Inc. | ARQT | Watanabe Todd Franklin President and CEO |
1,607 | $0 | 938,295 (Direct) |
View |
2021-05-05 Exercise |
2021-05-07 11:29 am |
N/A N/A |
Arcutis Biotherapeutics Inc. | ARQT | Watanabe Todd Franklin President and CEO |
1,607 | $1.6806 | 938,295 (Direct) |
View |
2021-05-03 Exercise |
2021-05-05 2:05 pm |
N/A 2029-03-13 |
Arcutis Biotherapeutics Inc. | ARQT | Welgus Howard G. Director |
2,200 | $0 | 284,555 (Direct) |
View |
2021-05-03 Exercise |
2021-05-05 2:05 pm |
N/A N/A |
Arcutis Biotherapeutics Inc. | ARQT | Welgus Howard G. Director |
1,028 | $6.522 | 284,555 (Direct) |
View |
2021-05-03 Exercise |
2021-05-05 2:05 pm |
N/A N/A |
Arcutis Biotherapeutics Inc. | ARQT | Welgus Howard G. Director |
1,172 | $1.6806 | 284,555 (Direct) |
View |
2021-04-16 Exercise |
2021-04-20 5:43 pm |
N/A 2029-03-13 |
Arcutis Biotherapeutics Inc. | ARQT | Welgus Howard G. Director |
2,655 | $0 | 291,198 (Direct) |
View |
2021-04-16 Exercise |
2021-04-20 5:43 pm |
N/A N/A |
Arcutis Biotherapeutics Inc. | ARQT | Welgus Howard G. Director |
1,222 | $0.5802 | 291,198 (Direct) |
View |
2021-04-16 Exercise |
2021-04-20 5:43 pm |
N/A N/A |
Arcutis Biotherapeutics Inc. | ARQT | Welgus Howard G. Director |
1,433 | $1.6806 | 291,198 (Direct) |
View |
2021-04-01 Option Award |
2021-04-05 6:50 pm |
N/A 2031-04-01 |
Arcutis Biotherapeutics Inc. | ARQT | Burrows Scott L Chief Financial Officer |
23,000 | $0 | 23,000 (Direct) |
View |
Ownership |
2021-04-05 6:49 pm |
N/A N/A |
Arcutis Biotherapeutics Inc. | ARQT | Burrows Scott L Chief Financial Officer |
0 | $0 | 97,012 (Direct) |
View |
2021-04-01 Exercise |
2021-04-05 5:33 pm |
N/A 2029-03-13 |
Arcutis Biotherapeutics Inc. | ARQT | Welgus Howard G. Director |
2,200 | $0 | 284,100 (Direct) |
View |
2021-04-01 Exercise |
2021-04-05 5:33 pm |
N/A N/A |
Arcutis Biotherapeutics Inc. | ARQT | Welgus Howard G. Director |
1,029 | $6.522 | 284,100 (Direct) |
View |
2021-04-01 Exercise |
2021-04-05 5:33 pm |
N/A N/A |
Arcutis Biotherapeutics Inc. | ARQT | Welgus Howard G. Director |
1,171 | $1.6806 | 284,100 (Direct) |
View |
2021-03-16 Exercise |
2021-03-18 1:59 pm |
N/A 2029-03-13 |
Arcutis Biotherapeutics Inc. | ARQT | Welgus Howard G. Director |
2,653 | $0 | 291,198 (Direct) |
View |
2021-03-16 Exercise |
2021-03-18 1:59 pm |
N/A N/A |
Arcutis Biotherapeutics Inc. | ARQT | Welgus Howard G. Director |
1,222 | $0.5802 | 291,198 (Direct) |
View |
2021-03-16 Exercise |
2021-03-18 1:59 pm |
N/A N/A |
Arcutis Biotherapeutics Inc. | ARQT | Welgus Howard G. Director |
1,431 | $1.6806 | 291,198 (Direct) |
View |
2021-03-10 Exercise |
2021-03-11 3:59 pm |
N/A 2029-05-14 |
Arcutis Biotherapeutics Inc. | ARQT | Smither John W Chief Financial Officer |
500 | $0 | 178,018 (Direct) |
View |
2021-03-10 Exercise |
2021-03-11 3:59 pm |
N/A N/A |
Arcutis Biotherapeutics Inc. | ARQT | Smither John W Chief Financial Officer |
500 | $1.6806 | 178,018 (Direct) |
View |
2021-03-03 Option Award |
2021-03-05 3:56 pm |
N/A 2031-03-03 |
Arcutis Biotherapeutics Inc. | ARQT | Watanabe Todd Franklin President and CEO |
131,900 | $0 | 907,003 (Direct) |
View |
2021-03-04 Exercise |
2021-03-05 3:55 pm |
N/A 2029-05-14 |
Arcutis Biotherapeutics Inc. | ARQT | Smither John W Chief Financial Officer |
12,396 | $0 | 260,770 (Direct) |
View |
2021-03-03 Option Award |
2021-03-05 3:55 pm |
N/A 2031-03-03 |
Arcutis Biotherapeutics Inc. | ARQT | Smither John W Chief Financial Officer |
38,300 | $0 | 260,770 (Direct) |
View |
2021-03-04 Exercise |
2021-03-05 3:55 pm |
N/A N/A |
Arcutis Biotherapeutics Inc. | ARQT | Smither John W Chief Financial Officer |
12,396 | $1.6806 | 260,770 (Direct) |
View |
2021-03-03 Option Award |
2021-03-05 3:54 pm |
N/A 2031-03-03 |
Arcutis Biotherapeutics Inc. | ARQT | Burnett Patrick See Remarks |
38,300 | $0 | 38,300 (Direct) |
View |
2021-03-03 Option Award |
2021-03-05 3:53 pm |
N/A 2031-03-03 |
Arcutis Biotherapeutics Inc. | ARQT | Lock Kenneth A. Chief Commercial Officer |
38,300 | $0 | 60,467 (Direct) |
View |
2021-03-03 Option Award |
2021-03-05 3:52 pm |
N/A 2031-03-03 |
Arcutis Biotherapeutics Inc. | ARQT | OSBORNE DAVID W Chief Technical Officer |
38,300 | $0 | 275,553 (Direct) |
View |
2021-03-03 Option Award |
2021-03-05 3:51 pm |
N/A 2031-03-03 |
Arcutis Biotherapeutics Inc. | ARQT | Turney Patricia A. SVP, Operations |
38,300 | $0 | 47,571 (Direct) |
View |